Changes in Beneficial Ownership · 4
DiaMedica Therapeutics Inc.
DMACNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
form4-06032026_090653.xml
Filing details
- Report period
- 2026-06-01
- Issuer
- DiaMedica Therapeutics Inc.
- Issuer CIK
- 0001401040
- Trading symbol
- DMAC
Reporting owner 1
- Name
- Kuntz Richard
- Reporting owner CIK
- 0001341125
- Relationship
- Director
- Address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | 5.84 | 2026-06-01 | A · Form 4 | 40,412 | A | 0 | [F1] | 2036-06-01 | Voting Common Shares | 40,412 | 40,412 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- Scheduled to vest in four equal quarterly installments.↩ 1
Signature 1
- Signed
- /s/ Joshua L. Colburn, attorney-in-fact
- Date
- 2026-06-03
Filed exhibits
- EX-24 ↗ex24-06032026_090657.htm